Health Care·Biotechnology·$28.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.39 | N/A | +6.47% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.39 | N/A | +6.47% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed a cautious approach, emphasizing operational improvements. They acknowledged the challenging market environment.
We are focusing on improving our operational efficiencies.
Market conditions remain challenging, but we are committed to our long-term strategy.
Natera's earnings report shows a slight beat on EPS, but the lack of revenue data and no guidance may raise concerns among investors. The stock reacted negatively, dropping 3.33%, likely due to uncertainties in the market and management's defensive tone during the call.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RBC BEARINGS INC
Nov 9, 2015